This archive spans the years 2017 through 2025, a period marked by rapid advances in clean energy, medicine, technology, and social equity. It collects documented breakthroughs, policy wins, and scientific achievements from the present era. If you want evidence that progress is real and ongoing, this is where to look.
The new provisions are part of French president Macron’s large-scale plan to heavily invest in renewables, which aims to multiply by 10 the amount of solar energy produced in the country.
According to a recent study for estimating the prevalence of blindness and visual impairment in the Indian population, more than one fourth of people in India aged 50 years and above are visually impaired.
Colorado’s Natural Medicine Health Act goes further than any previous U.S. state psychedelic law, removing criminal penalties for personal use of psilocybin, DMT, ibogaine, and mescaline — and building a licensed therapy clinic system alongside it. The FDA has already granted psilocybin “breakthrough therapy” status for treatment-resistant depression, giving this reform unusual clinical credibility. Colorado helped pioneer cannabis legalization in 2012, and advocates are watching to see whether psychedelic reform follows a similar path outward. For people who haven’t found relief through conventional treatments, this law opens a genuinely new door.
Rich nations, which bear the brunt of responsibility for warming the atmosphere, have long resisted making such payments, seeking to avoid assuming legal liability for their contributions to climate change.
Lab-grown blood cells have reached a genuine turning point: manufactured red blood cells grown from stem cells have been safely transfused into human patients for the first time. What makes these cells special is their freshness — unlike donated blood, every lab-grown cell is the same age, meaning they should last closer to the full 120-day lifespan and reduce repeat transfusions. Early participants completed the process with no adverse effects. For millions worldwide living with blood disorders or rare blood types, this science crossing into human trials is the kind of progress that quietly changes everything.
The age-adjusted prevalence of dementia declined from 12.2 percent of people over age 65 in 2000 to 8.5 percent of people over age 65 in 2016—a nearly one-third drop from the 2000 level, according to a new RAND Corporation study.
This decision puts Icelandair at the forefront of sustainable aviation, considering that many other airlines are only aiming to reach net-zero emissions by 2050.
Maternal vaccination reduced rates of severe medically attended lower respiratory tract illness due to RSV by 81.8% across the first three months of life.
The small island nation in the South Pacific Ocean has designated its entire exclusive economic zone — an area about the size of Vietnam — as a multiple-use marine park called Niue Nukutuluea.
This “monumental” breakthrough formally ends a two-year war that has displaced millions and threatened to destabilize a swath of the continent.
